Compare Datadog Inc (DDOG) vs Quest Diagnostics Inc (DGX) Price & Performance

Datadog (DDOG) trades at $273.80, up 0.91% with strong bullish technical momentum as it approaches its 52-week high. The company demonstrates robust revenue growth, reaching $3.43B in 2025, though net margins remain modest at 3.14%. Recent earnings beats and accelerating enterprise customer expansion support positive sentiment, with 83% of analysts maintaining buy ratings and a $277.23 consensus target.

Outlook remains favorable with AI-driven observability demand and international expansion driving growth. Key risks include elevated valuation multiples (P/E 547.6) and competitive pressures in cloud monitoring. The stock presents growth opportunity but requires monitoring of margin improvement and execution against high expectations.

Quest Diagnostics (DGX) trades at $230.81, up 1.68% with strong year-to-date performance driven by organic growth and advanced diagnostics adoption. The company has consistently beaten earnings expectations in recent quarters with Q2 2026 EPS of $3.12 exceeding estimates. Technical indicators show a bearish bias while fundamentals remain solid with 9.19% net margin and 14.35% ROE. Recent developments include a partnership with Apple Health app and positive clinical study results.

DGX presents a mixed outlook with strong fundamental performance offset by technical weakness and regulatory headwinds. The 38% upside to consensus price target of $250 offers potential, but Medicare reimbursement cuts and bearish technical signals warrant caution. Growth in consumer testing and strategic partnerships provide catalysts, though execution risks and debt levels require monitoring.